RCS - Intelligent Ultrasnd - Mello investor conference

Intelligent UltrasoundAnnouncement

18/05/2023 07:00

For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20230518:nRSR7768Za&default-theme=true

RNS Number : 7768Z  Intelligent Ultrasound Group PLC  18 May 2023

Intelligent Ultrasound Group plc

(the "Group" or the "Company")

 

Mello investor conference

 

Intelligent Ultrasound Group plc (AIM: IUG), the 'classroom to clinic'
ultrasound company, specialising in artificial intelligence (AI) software and
simulation announces that Stuart Gall, Chief Executive Officer, will be
presenting at the Mello2023 investor conference on Tuesday, 23 May to be held
at the Clayton Hotel Chiswick, Chiswick High Road, London, W4 5RY.

 

For further information and tickets (use code SHME100 for complimentary
entry on Tuesday) for the Mello2023 conference, please visit the event website
at https://melloevents.com/mello2023tickets/
(https://melloevents.com/mello2023tickets/)

 

For further information, please contact:

 

 Intelligent Ultrasound Group plc                www. intelligentultrasound.com
 Stuart Gall, CEO                                Tel: +44 (0)29 2075 6534
 Helen Jones, CFO

 Cenkos Securities - Nominated Advisor and Broker                Tel:  +44 (0)20 7397 8900
 Giles Balleny / Max Gould (Corporate Finance)
 Michael Johnson / Julian Morse (Sales)

 Walbrook PR     Tel: +44 (0)20 7933 8780 or intelligentultrasound@walbrookpr.com
 Anna Dunphy                     Mob: +44 (0)7876 741 001

 

 

ABOUT INTELLIGENT ULTRASOUND GROUP

 

Intelligent Ultrasound (AIM: IUG) is one of the world's leading 'classroom to
clinic' ultrasound companies, specialising in real-time hi-fidelity virtual
reality simulation for the ultrasound training market ('classroom') and
artificial intelligence-based clinical image analysis software tools for the
diagnostic medical ultrasound market ('clinic'). Based in Cardiff in the UK
and Atlanta in the USA, the Group has two revenue streams:

 

Simulation

 

Real-time hi-fidelity ultrasound education and training through simulation.
Our main products are the ScanTrainer obstetrics and gynaecology training
simulator, the HeartWorks echocardiography training simulator, the BodyWorks
Eve Point of Care and Emergency Medicine training simulator with Covid-19
module and the new BabyWorks Neonate and Paediatric training simulator. To
date c. 1500 simulators have been sold to over 750 medical institutions around
the world.

 

Clinical AI software

 

Deep learning-based algorithms to make ultrasound machines smarter and more
accessible using our proprietary ScanNav ultrasound image analysis technology.
Current products on the market utilising this technology are GE HealthCare's
SonoLyst software that is incorporated in their Voluson Expert 22 and SWIFT
ultrasound machines; ScanNav Anatomy PNB that simplifies ultrasound image
interpretation by providing the user with real-time AI-based anatomy
highlighting for a range of ultrasound guided regional anaesthesia procedures;
and NeedleTrainer that teaches real-time ultrasound-guided needling and
incorporates ScanNav Anatomy PNB.

This information is provided by Reach, the non-regulatory press release distribution service of RNS, part of the London Stock Exchange. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  NRAEDLFFXELLBBL